VVP
LLY icon

Venture Visionary Partners’s Eli Lilly LLY Stock Holding History

Venture Visionary Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$231K Buy
+200
New +$236K 0.01% 625

Other funds holding LLY

SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return

Venture Visionary Partners's LLY Position: Q3 2026 in Review

Venture Visionary Partners increased its Eli Lilly (LLY) stake by 5.4% in Q3 2026, buying an estimated $899K and bringing the position to 14,917 shares worth $17.3M. The position accounts for 0.45% of the portfolio, ranked #54.

Venture Visionary Partners first reported a position in LLY in Q4 2020 and has held it in 24 quarters since. 269 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Venture Visionary Partners held 14,917 shares of Eli Lilly worth $17.3M as of Q3 2026.
  • Venture Visionary Partners bought 762 Eli Lilly shares in Q3 2026, an estimated $899K.
  • Eli Lilly made up 0.45% of Venture Visionary Partners's portfolio in Q3 2026, its #54 holding.
  • Venture Visionary Partners first reported a position in Eli Lilly in Q4 2020 and has held it in 24 quarters since.
  • 269 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Venture Visionary Partners's 13F filing for Q3 2026, filed 7 Oct 2026.